Featured Research

from universities, journals, and other organizations

Blood-brain Barrier: A Misunderstood Key To Finding Life-saving Cures To Brain Disease

Date:
December 21, 2007
Source:
Saint Louis University
Summary:
Scientists demystify the blood-brain barrier. They suggest several strategies to propel research for treatments of brain diseases that include multiple sclerosis, Alzheimer's disease, obesity and stroke.

An international team of scientists that includes a Saint Louis University researcher suggest several strategies to propel research for treatments of brain diseases that include multiple sclerosis, Alzheimer's disease, obesity and stroke in the January issue of the Lancet Neurology.

Related Articles


The blood-brain barrier is a gate-keeping system of cells that protects the brain from toxins and lets in nutrients. Because it passes no judgment on which foreign substances are there to treat diseases and which are penetrating the brain to do harm, it locks all of them out. That makes getting drugs into the brain where they can do their work in treating brain diseases difficult.

"A big part of our work is raising the awareness about the blood-brain barrier as an intimate part of the disease process," said William A. Banks, M.D., professor of geriatrics and pharmacological and physiological science at Saint Louis University School of Medicine, and a member of the research team.

"You can't get drugs into the brain or understand brain disease without understanding the blood-brain barrier, which is among our most significant recommendations for future research."

The blood-brain barrier is woefully misunderstood, said Banks, who also is a staff physician at Veterans Affairs Medical Center in St. Louis.

"The general theme of our review article is the blood-brain barrier is not a brick wall but a regulating interface between the brain and the rest of the body. Look at the brain as an island, where all raw materials have to be imported. The blood-brain barrier is the shipping and communications system that connects the island (the brain) to the rest of the world (the body)."

Sometimes the blood-brain barrier lets in things that it shouldn't and doesn't let out things that it should. Learning more about the secrets of the blood-brain barrier system is critical in understanding Alzheimer's disease, for instance, because the BBB makes it difficult to target medication where it's needed in the brain and won't allow toxic amyloid beta proteins, believed to cause Alzheimer's, to drain out of the brain.

Much of Banks' work focuses on the function of the blood-brain barrier in regulating the immune system, the body's natural defense in fighting disease. The cells that make up the blood-brain barrier help the brain and immune system communicate, he explained.

The crash of that communication system can impact diseases including Alzheimer's disease, stroke and multiple sclerosis. In the Lancet Neurology article, Banks and his colleagues called for more research to better understand how the blood-brain barrier relates to immune cells.

The article also recommended wider use of state-of-the-art imaging to examine how the blood-brain barrier and the rest of central nervous system interact, particularly in patients who have spinal cord injuries, head trauma and stroke.

Changes to the blood-brain barrier could give important clues about injuries to the central nervous system and the growth of tumors.

The review also called for investigators from various disciplines and who work in different institutions and laboratories to collaborate on blood-brain barrier research to take research from an animal model to patient clinical trials.

Their review article, which focuses on surmounting obstacles posed by the blood-brain barrier (BBB), is available in an early online edition on Dec. 17.

An international committee of 14 scientists who specialize in blood-brain barrier research wrote the review article. In addition to SLU and the VA, participating institutions included Oregon Health & Science University, King's College, Memorial Sloan-Kettering Cancer Center, University of Manitoba, University of Arizona, University of Bern, Texas Tech University Health Sciences Center, University of Rochester, University of California Los Angeles, University of New Mexico and University of Minnesota Medical School.


Story Source:

The above story is based on materials provided by Saint Louis University. Note: Materials may be edited for content and length.


Cite This Page:

Saint Louis University. "Blood-brain Barrier: A Misunderstood Key To Finding Life-saving Cures To Brain Disease." ScienceDaily. ScienceDaily, 21 December 2007. <www.sciencedaily.com/releases/2007/12/071218101237.htm>.
Saint Louis University. (2007, December 21). Blood-brain Barrier: A Misunderstood Key To Finding Life-saving Cures To Brain Disease. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2007/12/071218101237.htm
Saint Louis University. "Blood-brain Barrier: A Misunderstood Key To Finding Life-saving Cures To Brain Disease." ScienceDaily. www.sciencedaily.com/releases/2007/12/071218101237.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins